Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Conserved and variant epitopes of Plasmodium vivax Duffy binding protein as targets of inhibitory monoclonal antibodies.

Ntumngia FB, Schloegel J, Barnes SJ, McHenry AM, Singh S, King CL, Adams JH.

Infect Immun. 2012 Mar;80(3):1203-8. doi: 10.1128/IAI.05924-11. Epub 2012 Jan 3.

2.

Finding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding protein.

Ntumngia FB, King CL, Adams JH.

Int J Parasitol. 2012 Nov;42(12):1055-62. doi: 10.1016/j.ijpara.2012.09.006. Epub 2012 Oct 12. Review.

3.

Vaccination for vivax malaria: targeting the invaders.

Polley SD, McRobert L, Sutherland CJ.

Trends Parasitol. 2004 Mar;20(3):99-102. Review.

PMID:
16676415
4.

The Duffy binding protein as a key target for a Plasmodium vivax vaccine: lessons from the Brazilian Amazon.

de Sousa TN, Kano FS, de Brito CF, Carvalho LH.

Mem Inst Oswaldo Cruz. 2014 Aug;109(5):608-17. Review.

5.

Plasmodium vivax malaria vaccine development.

Arévalo-Herrera M, Herrera S.

Mol Immunol. 2001 Dec;38(6):443-55. Review.

PMID:
11741694
6.

Targeting the Plasmodium vivax Duffy-binding protein.

Chitnis CE, Sharma A.

Trends Parasitol. 2008 Jan;24(1):29-34. Epub 2007 Nov 26. Review.

PMID:
18023618
7.

An update on the search for a Plasmodium vivax vaccine.

Herrera S, Corradin G, Arévalo-Herrera M.

Trends Parasitol. 2007 Mar;23(3):122-8. Epub 2007 Jan 29. Review.

PMID:
17258937
Items per page

Supplemental Content

Write to the Help Desk